Systems biology of human benzene exposure

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 86-93

  Zhang, Luoping ^a   McHale, Cliona M ^a   Rothman, Nathaniel ^b   Li, Guilan ^c   Ji, Zhiying ^a   Vermeulen, Roel ^d   Hubbard, Alan E ^a   Ren, Xuefeng ^a   Shen, Min ^b   Rappaport, Stephen M ^a   North, Matthew ^e   Skibola, Christine F ^a   Yin, Songnian ^c   Vulpe, Christopher ^e   Chanock, Stephen J ^b   Smith, Martyn T ^a   Lan, Qing ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benzene; Epigenetics; Hematotoxicity; Human; Systems biology; Toxicogenomics

Indexed keywords

BENZENE; BIOLOGICAL MARKER; MICRORNA;

BIOINFORMATICS; BLOOD CELL COUNT; BLOOD TOXICITY; CELL CULTURE; CELL MATURATION; DNA METHYLATION; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; MICROARRAY ANALYSIS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; OCCUPATIONAL EXPOSURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; REVIEW; RNA INTERFERENCE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SYSTEMS BIOLOGY; TOXICOGENETICS; TRANSCRIPTOMICS;

BENZENE; COMPUTATIONAL BIOLOGY; EPIGENESIS, GENETIC; HEMATOPOIETIC SYSTEM; HUMANS; SYSTEMS BIOLOGY; TOXICOGENETICS;

EID: 77950627558     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.12.011     Document Type: Review

References (56)

1. Kirschner M.W. The meaning of systems biology. Cell 2005, 121:503-504.
2. Kitano H. Systems biology: a brief overview. Science (New York, NY) 2002, 295:1662-1664.
3. McHale C., Zhang L., Hubbard A.E., Smith M. Toxicogenomic studies in human populations. Applications of Toxicogenomics in Safety Evaluation and Risk Assessment 2010, John Wiley & Sons, Inc., Hoboken, NJ. D.R. Boverhof, B.B. Gollapudi (Eds.).
4. Smith M., Rappaport S. Building exposure biology centers to put the E into " G×E" interaction studies. Environ. Health Perspect. 2009, 117:A334-A335.
5. Vlaanderen J., Moore L.E., Smith M.T., et al. Application of omics technologies in occuptional and environmental health research: current status and projections. Occup. Environ. Med. 2009, http://www.ncbi.nlm.nih.gov/pubmed/19933307?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPaneL.Pubmed_RVDocSum&ordinalpos=2.
6. Bayat A. Science, medicine, and the future: bioinformatics. BMJ 2002, 324:1018-1022.
7. National Research Council (NRC) Toxicity Testing in the 21st Century: A Vision and a Strategy, Committee on Toxicity Testing and Assessment of Environmental Agents 2007, National Academies Press, Washington, DC.
8. Glass D.C., Gray C.N., Jolley D.J., et al. Leukemia risk associated with low-level benzene exposure. Epidemiology (Cambridge, MA) 2003, 14:569-577.
9. Hayes R.B., Songnian Y., Dosemeci M., Linet M. Benzene and lymphohematopoietic malignancies in humans. Am. J. Ind. Med. 2001, 40:117-126.
10. Savitz D.A., Andrews K.W. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am. J. Ind. Med. 1997, 31:287-295.
11. Smith M.T., Jones R.M., Smith A.H. Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomark. Prev. 2007, 16:385-391.
12. Zhang L., Eastmond D.A., Smith M.T. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit. Rev. Toxicol. 2002, 32:1-42.
13. International Agency for Research on Cancer (IARC) Some Industrial Chemicals and Dyestuffs, Monogr. Eval. Carcinog. Risks Hum. 1982.
14. International Agency for Research on Cancer (IARC) Monographs on the Evaluation of Carcinogenic Risks to Humans Overall Evaluations of Carcinogenicity, An Updating of IARC Monographs 1987.
15. Smith M.T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 1996, 104(Suppl. 6):1219-1225.
16. Ross D., Siegel D., Schattenberg D.G., Sun X.M., Moran J.L. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environ. Health Perspect. 1996, 104(Suppl. 6):1177-1182.
17. Snyder R., Hedli C.C. An overview of benzene metabolism. Environ. Health Perspect. 1996, 104(Suppl. 6):1165-1171.
18. Subrahmanyam V.V., Ross D., Eastmond D.A., Smith M.T. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic. Biol. Med. 1991, 11:495-515.
19. Zhang L., Smith M., Bandy B., Tamaki S.J., Davison A.J. Role of Quinones, active oxygen species and metals in the genotoxicity of 1,2,4-benzenetriol, a metabolite of benzene. Free Radicals in the Environment, Medicine and Toxicology 1994, 521-562. Richelieu, London. H. Nhol, H. Esterbauer, C. Rice-Evans (Eds.).
20. Cho J.Y. Suppressive effect of hydroquinone, a benzene metabolite, on in vitro inflammatory responses mediated by macrophages, monocytes and lymphocytes. Mediat. Inflamm. 2008, 298010.
21. Ouyang Y., Virasch N., Hao P., et al. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J. Allergy Clin. Immunol. 2000, 106:280-287.
22. Yoon B.I., Hirabayashi Y., Kawasaki Y., et al. Aryl hydrocarbon receptor mediates benzene-induced hematotoxicity. Toxicol. Sci. 2002, 70:150-156.
23. Pedersen-Bjergaard J., Andersen M.K., Andersen M.T., Christiansen D.H. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2008, 22:240-248.
24. Zhang L., Rothman N., Wang Y., et al. Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis 1998, 19:1955-1961.
25. Ji Z., Zhang L., Guo W., McHale C.M., Smith M.T. The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells. Mutagenesis 2009, 24:367-372.
26. Smith M.T., Zhang L., Wang Y., et al. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res. 1998, 58:2176-2181.
27. Lan Q., Zhang L., Li G., et al. Hematotoxicity in workers exposed to low levels of benzene. Science (New York, NY) 2004, 306:1774-1776.
28. Lan Q., Vermeulen R., Zhang L., et al. Benzene exposure and hematotoxicity. Science (New York, NY) 2006, 312:998-999.
29. Forrest M.S., Lan Q., Hubbard A.E., et al. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ. Health Perspect. 2005, 113:801-807.
30. McHale C.M., Zhang L., Lan Q., et al. Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms. Genomics 2009, 93:343-349.
31. McHale C., Zhang L., Lan Q., et al. Low-dose, occupational exposure to the leukemogen benzene induces robust changes in the blood transcriptome associated with altered immune system biology 2008, American Society of Hematology, San Francisco, CA.
32. Vermeulen R., Lan Q., Zhang L., et al. Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:17041-17046.
33. Dolinoy D.C., Jirtle R.L. Environmental epigenomics in human health and disease. Environ. Mol. Mutagen. 2008, 49:4-8.
34. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. 2007, 8:253-262.
35. Bollati V., Baccarelli A., Hou L., et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007, 67:876-880.
36. Muller C.I., Luong Q.T., Shih L.Y., et al. Identification of marker genes including RUNX3 (AML2) that discriminate between different myeloproliferative neoplasms and normal individuals. Leukemia 2008, 22:1773-1778.
37. Neufeld G., Shraga-Heled N., Lange T., et al. Semaphorins in cancer. Front. Biosci. 2005, 10:751-760.
38. Kim E., Kang B.Y., Kim T.S. Inhibition of interleukin-12 production in mouse macrophages by hydroquinone, a reactive metabolite of benzene, via suppression of nuclear factor-kappaB binding activity. Immunol. Lett. 2005, 99:24-29.
39. Paschka P Core binding factor acute myeloid leukemia. Semin. Oncol. 2008, 35:410-417.
40. Dixon-McIver A., East P., Mein C.A., et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 2008, 3:e2141.
41. Skibola C.F., Bracci P.M., Halperin E., et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat. Genet. 2009, 41:873-875.
42. Knight J.A., Skol A.D., Shinde A., et al. Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood 2009, 113:5575-5582.
43. Crowley J.J., Sullivan P.F., McLeod H.L. Pharmacogenomic genome-wide association studies: lessons learned thus far. Pharmacogenomics 2009, 10:161-163.
44. North M., Shuga J., Loguinov A., et al. Utilizing functional genomics in yeast to discover novel biomarkers of benzene toxicity in humans. International Symposium on Benzene Health Effects and Mechanisms of Bone Marrow Toxicity 2009.
45. Van der Laan M.J., Pollard K.S. A new algorithm for hybrid hierarchial clustering with visualization and the bootstrap. J. Stat. Plann. Inference 2003, 275-303.
46. Cline M.S., Smoot M., Cerami E., et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2007, 2:2366-2382.
47. Maere S., Heymans K., Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics (Oxford, England) 2005, 21:3448-3449.
48. Galvan N., Lim S., Zmugg S., Smith M.T., Zhang L. Depletion of WRN enhances DNA damage in HeLa cells exposed to the benzene metabolite, hydroquinone. Mutat. Res. 2008, 649:54-61.
49. Ren X, Lim S., Smith M.T., Zhang L. Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone. Toxicol. Sci. 2009, 107:367-375.
50. Lan Q., Zhang L., Shen M., et al. Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis 2009, 30:50-58.
51. Lan Q., Zhang L., Shen M., et al. Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene. Cancer Res. 2005, 65:9574-9581.
52. Shen M., Lan Q., Zhang L., et al. Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis 2006, 27:2083-2089.
53. Singh D.K., Ahn B., Bohr V.A. Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging. Biogerontology 2009, 10:235-252.
54. Mattingly C.J, Rosenstein M.C., Colby G.T., Forrest J.N., Boyer J.L. The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. J. Exp. Zool. A: Comp. Exp. Biol. 2006, 305:689-692.
55. Waters M., Stasiewicz S., Merrick B.A., et al. CEBS-Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data. Nucleic Acids Res. 2008, 36:D892-900.
56. Edwards S.W., Preston R.J. Systems biology and mode of action based risk assessment. Toxicol. Sci. 2008, 106:312-318.